New Publication! Strengthen Tumor Market Testing with CLSI C65 Biochemical tumor marker plays a critical role in diagnosis, monitoring, and clinical decision making. With increasing pressure on laboratories to ensure accuracy and consistency across preexamination, examination, and postexamination processes, the new CLSI C65 standard provides the guidance needed to reduce risk and improve confidence in patient results. Practical…
Ben KempMarch 2, 2026